Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

BlackRock Commentary: Why we like emerging market assets

Wei Li, Global Chief Investment Strategist together with Scott Thiel, Chief Fixed Income Strategist, Ben Powel, Chief Investment Strategist for APAC, and Beata Harasim, Senior Investment Strategist, all part of the BlackRock Investment Institute, share their insights on global economy, markets and geopolitics. Their views are theirs alone and are not intended to be construed as investment advice.


We see the economic restart and greater stability in U.S. government bond yields – as indicated by our new nominal theme – supporting emerging market assets over coming months. Their valuations appear relatively attractive in a world of low yields after a choppy start to the year. Risks to our view include potential policy tightening and sluggish vaccine rollouts in some EMs.

20.04 Article Image 1

Past performance is not a reliable indicator of current or future results. Indexes are unmanaged and not subject to fees. You cannot invest directly in an index. Sources: BlackRock Investment Institute, with data from Refinitiv, April 2021. Notes: U.S. high yield debt is represented by the Bloomberg Barclays U.S. Corporate High Yield Index, and EM local-currency debt by the JPMorgan GBI-EM Global Diversified Index.

 

U.S. Treasury yields and the U.S. dollar are key drivers for EM assets. Treasury yields spiked earlier in the year, leading to a sharp rise in EM yields. We think the spike was justified and reflected the faster-than-expected activity restart combined with large U.S. fiscal stimulus. We see greater stability in yields and in the U.S. dollar over coming months, with our new nominal theme confirmed by the Federal Reserve’s comments and recent market moves. This should support EM local-currency debt, in our view. Its valuation appears attractive relative to other income sources such as high yield debt, as the chart above shows. Support also comes from loose global financial conditions that make it relatively easy to borrow for now, and reduced foreign ownership in this market that helps keep contagion risk in check. We also see room for EM currencies – especially from commodity exporters – to advance, as these currencies have yet to fully reflect the commodity rally. There is a large dispersion within EM fundamentals and that demands a selective approach. See our Emerging markets marker.

Some EMs face near-term challenges including a virus resurgence, slow vaccine rollouts and rising inflation that may force the hand of their central banks. Yet we expect their economic restart to likely be delayed – but not derailed. We are overall positive on broad EM and Asia ex-Japan equities in particular over the next six to 12 months, expecting these assets to be well positioned to benefit from a vaccine-led global restart. We also see the need to be selective in EM equities. The powerful economic restart is likely to support many commodities in the near term, including oil. This should benefit the assets of commodity exporters, including some EMs, as we argued last week. Copper prices have rallied since last year as a result of a supply shortage and activity restart in key consumers including China. We see structural demand for copper and certain industrial metals associated with a transition toward a low-carbon economy for years to come. This should support prices and likely benefit EM exporters of copper and other commodities, in our view.

We see China exposures as core strategic holdings that are distinct from EM exposures. There are near-term risks in China including an anti-monopoly drive that threatens large-cap Internet companies – a large component of EM benchmark indexes – that pushes us to favour more cyclical and domestically oriented exposures. And even with such risks we still favor strategic above-benchmark allocations to assets exposed to China, including Chinese equities and government bonds. The pandemic has accelerated the rewiring of globalization – with a bipolar U.S.-China world order at its center. We believe it’s key for investors to have exposures to both engines of global growth.

The bottom line: We expect our new nominal theme – a more muted response in nominal yields to higher inflation expectations – to hold as we move toward a full reopening. The U.S. dollar has strengthened so far this year, reflecting the faster-than-expected restart in the U.S. fueled by an accelerated vaccine rollout and large fiscal spending. We expect the rise in the dollar to take a pause as markets start reflecting expectations for the reopening to broaden out, easing some pressure on EM assets. We stay overweight EM and Asia ex-Japan equities, and are warming up to EM local-currency debt as a source of income. Potential risks to our views include the deteriorating creditworthiness of many EMs as a result of massive fiscal expansion last year. Policymakers in these countries may be faced with the challenge of needing to tighten policies even as their economies still operate well below potential.

Market Updates

20.04 Article Image 2

Past performance is not a reliable indicator of current or future results. Indexes are unmanaged and do not account for fees. It is not possible to invest directly in an index. Sources: BlackRock Investment Institute, with data from Refinitiv Datastream as of April 15, 2021. Notes: The two ends of the bars show the lowest and highest returns at any point this year to date, and the dots represent current year-to-date returns. Emerging market (EM), high yield and global corporate investment grade (IG) returns are denominated in U.S. dollars, and the rest in local currencies. Indexes or prices used are, in descending order: spot Brent crude, MSCI USA Index, MSCI Europe Index, MSCI Emerging Markets Index, the ICE U.S. Dollar Index (DXY), Bank of America Merrill Lynch Global High Yield Index, Refinitiv Datastream Italy 10-year benchmark government bond index,, Refinitiv Datastream Germany 10-year benchmark government bond index, Bank of America Merrill Lynch Global Broad Corporate Index, J.P. Morgan EMBI index, Refinitiv Datastream U.S. 10-year benchmark government bond index and spot gold.

Market backdrop

U.S. stocks hit new record highs and 10-year Treasury yields dropped to the lowest level in more than a month. Major U.S. banks reported positive earnings for the first quarter.  We expect equities and other risk assets to be supported by the new nominal – a more muted response of government yields to stronger growth and higher inflation than in the past as central banks lean against any sharp yield rises.

Week Ahead

  • April 22 – European Central Bank (ECB) policy meeting; euro area consumer confidence
  • April 23 – U.S., euro area, UK and Japan composite purchasing managers’ index (PMI)

This week’s PMI data from key developed economies could help gauge the progress of the economic restart. We expect the pent-up demand among U.S. consumers to unleash with the accelerated vaccine rollout, benefitting contact-intensive services. We don’t expect any policy change from the ECB’s policy meeting, after it decided to increase the pace of bond purchases under its Pandemic Emergency Purchase Program (PEPP) to stem a rise in bond yields at the March meeting.


BlackRock’s Key risks & Disclaimers:

This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of April 19th, 2021 and may change. The information and opinions are derived from proprietary and non-proprietary sources deemed by BlackRock to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by BlackRock, its officers, employees or agents. This material may contain ’forward looking’ information that is not purely historical in nature. Such information may include, among other things, projections and forecasts. There is no guarantee that any forecasts made will come to pass. Reliance upon information in this material is at the sole discretion of the reader.

The information provided here is neither tax nor legal advice. Investors should speak to their tax professional for specific information regarding their tax situation. Investment involves risk including possible loss of principal. International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation, and the possibility of substantial volatility due to adverse political, economic or other developments. These risks are often heightened for investments in emerging/developing markets or smaller capital markets. 

Issued by BlackRock Investment Management (UK) Limited, authorized and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from  BlackRock Investment Management (UK) Limited. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

Why we stay risk-on in the short term
All News

BlackRock Commentary: Why we stay risk-on in the short term

Last week’s central bank actions buoyed market sentiment, prompting BlackRock to maintain a pro-risk stance in their tactical outlook for the next six to twelve months as Q2 begins. Despite lingering concerns about persistent U.S. inflation and diminishing expectations of Federal Reserve rate cuts, they observe that stock markets are resilient.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.